ICURE PHARMACEUTICAL INC. – Trademark Portfolio
Entity Type: 03
ICURE PHARMACEUTICAL INC. holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 4 Nice Classification classes. Currently, 11 trademarks are registered. Notable registered marks include HIQZIL, PIIURB, LEAFDAM, BEAUTREE, and PEZLAYER. The owner is based in SEOUL.
10, BONGEUNSA-RO 104-GIL, GANGNAM-GU
SEOUL 06170 , KR
Showing of trademarks Trademarks
Trademark Classifications
ICURE PHARMACEUTICAL INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does ICURE PHARMACEUTICAL INC. have?
ICURE PHARMACEUTICAL INC. has 13 U.S. trademarks filed with the USPTO. Of these, 11 registered, 2 abandoned.
What trademark classes does ICURE PHARMACEUTICAL INC. file in?
ICURE PHARMACEUTICAL INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 35 (Advertising & Business), Class 40 (Treatment & Processing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are ICURE PHARMACEUTICAL INC.'s most well-known trademarks?
ICURE PHARMACEUTICAL INC.'s registered trademark portfolio includes well-known marks such as HIQZIL, PIIURB, LEAFDAM, BEAUTREE, and PEZLAYER. These are among 11 currently registered trademarks in the portfolio.
What is ICURE PHARMACEUTICAL INC.'s trademark registration success rate?
ICURE PHARMACEUTICAL INC. has a 85% trademark registration rate, with 11 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.